This just in: A Kentucky company says it has developed hemp plants that don’t contain any THC. THC is the main psychoactive component in marijuana. The announcement comes from GenCanna Global and University of Kentucky researchers. It’s being hailed as a breakthrough in the global hemp industry. State growers and processors have struggledRead More →
Science writer Laura Elizabeth Lansdowne interviews cannabis researcher Ethan Russo, MD about the role of terpenes in cannabis composition. From the article: Terpenoids are responsible for the unique aroma of cannabis. These compounds are lipophilic, can permeate lipid membranes, and several are capable of crossing the blood-brain barrier after inhalation.Read More →
Duke Health study points to changes to genetic profile of human sperm after exposure to cannabis. The study may indicate extra care that men of child-bearing age might want to take in terms of managing their reproductive health in this regard. “What we have found is that the effects ofRead More →
Canada continues to lead the way in terms of applied cannabis research. The Ontario Long Term Care Association is embarking on a study of 500 seniors in the Ontario region to study the effects of cannabis use among seniors in long-term care. The outcomes of the study will inform policyRead More →
JAMA Network Open recently published a report entitled “Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis.” The piece presented the main questions examined in the study: How does smoked and vaporized cannabis acutely influence subjective drug effects, cognitive and psychomotor performance, and cardiovascular measures inRead More →
In a focused effort to study the potential impact cannabinoid-based medical interventions may have on reducing opioid use for pain reduction, Perth-based Zelda Therapeutics LTD has established a partnership with St. Vincent’s Hospital in Melbourne to conduct clinical trials to study potential uses for these treatments. Subjects who have becomeRead More →
In a ground-breaking $100m deal with Canadian Cronos Group, a Boston company called Ginkgo Bioworks has been charged with perfecting the process of producing synthetic cannabinoids from organisms, such as yeast, that have been genetically altered. According to The Guardian, the modified organisms would act as the engines that convertRead More →